Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Supplement Pulled for Containing Undeclared Drug
12/07/2023
Jolynn Tumolo
According to the December 6, 2023, FDA Enforcement Report, the recall affects all Kuka Flex Forte caplets (UPC 0736640810265), which are packaged in 100-count bottles. The caplets were manufactured by Kukamonga, Guadalajara, Jalisco, Mexico,...
According to the December 6, 2023, FDA Enforcement Report, the recall affects all Kuka Flex Forte caplets (UPC 0736640810265), which are packaged in 100-count bottles. The caplets were manufactured by Kukamonga, Guadalajara, Jalisco, Mexico,...
According to the December 6,...
12/07/2023
Pharmacy Learning Network
News
Tablets Under Recall for Undeclared Drug Ingredient
12/07/2023
Jolynn Tumolo
“Consumption of undeclared diclofenac could result in serious adverse events that include cardiovascular, gastrointestinal, renal, and anaphylaxis in patients taking concomitant NSAIDs and/or anticoagulants, such as warfarin, in those who...
“Consumption of undeclared diclofenac could result in serious adverse events that include cardiovascular, gastrointestinal, renal, and anaphylaxis in patients taking concomitant NSAIDs and/or anticoagulants, such as warfarin, in those who...
“Consumption of undeclared...
12/07/2023
Pharmacy Learning Network
News
The Impact of Opioid Addiction on Child Suicide Rates in the United States
12/06/2023

Danielle Sposato

Danielle Sposato
David Powell, PhD, aimed to define the correlation between illicit opioid use and child suicide rates in the US. His research outlines that although experts consider both crises independent, findings show that both may be connected.
David Powell, PhD, aimed to define the correlation between illicit opioid use and child suicide rates in the US. His research outlines that although experts consider both crises independent, findings show that both may be connected.
David Powell, PhD, aimed to...
12/06/2023
Pharmacy Learning Network

Advertisement

News
A Shift Towards Transparency: CVS Health Announces New Drug Pricing and Payment Model
12/05/2023
Hannah Musick
CVS Health plans to upend how American pharmacies are paid by shifting to a simpler payment model based on the purchase price of drugs, potentially bringing more transparency and accountability to drug pricing and mixed effects on consumers,...
CVS Health plans to upend how American pharmacies are paid by shifting to a simpler payment model based on the purchase price of drugs, potentially bringing more transparency and accountability to drug pricing and mixed effects on consumers,...
CVS Health plans to upend how...
12/05/2023
Pharmacy Learning Network
News
Uncovering the Evolutionary Origins of Glycopeptide Antibiotics: A Pathway to Future Antibiotics
12/04/2023
Hannah Musick
Researchers reconstructing the genetic pathways to create an ancient molecule known as "paleomycin” led to the discovery that all glycopeptide antibiotics come from a common precursor.
Researchers reconstructing the genetic pathways to create an ancient molecule known as "paleomycin” led to the discovery that all glycopeptide antibiotics come from a common precursor.
Researchers reconstructing the...
12/04/2023
Pharmacy Learning Network
News
Navigating the Opioid Epidemic: Research Insights, the DSM-5, and the Mainstreaming Addiction Treatment Act
12/04/2023

Danielle Sposato

Danielle Sposato
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on...
12/04/2023
Pharmacy Learning Network

Advertisement

News
FDA Approves First Oral Medication for Treatment of Postpartum Depression
11/30/2023

Jessica Ganga

Jessica Ganga
In October, the FDA has approved zuranolone to treat postpartum depression (PPD) in adults—the first oral medication indicated to treat PPD.
In October, the FDA has approved zuranolone to treat postpartum depression (PPD) in adults—the first oral medication indicated to treat PPD.
In October, the FDA has approved...
11/30/2023
Pharmacy Learning Network
News
Vanilla Topical Antiseptic Recalled
11/29/2023
Jolynn Tumolo
The recall affects Integrity Biochem HSC 70-VA, alcohol antiseptic 70%, hand sanitizer, vanilla-scented topical gel, in a 55-gallon drum (NDC 77512-052-03), from lot 2134106 (manufacturing date 11/23/21). No expiration date is available.
The recall affects Integrity Biochem HSC 70-VA, alcohol antiseptic 70%, hand sanitizer, vanilla-scented topical gel, in a 55-gallon drum (NDC 77512-052-03), from lot 2134106 (manufacturing date 11/23/21). No expiration date is available.
The recall affects Integrity...
11/29/2023
Pharmacy Learning Network
News
Lemon Hand Sanitizer Recalled
11/29/2023
Jolynn Tumolo
The recall affects Integrity Biochem HSC 70-LM, alcohol antiseptic 70%, hand sanitizer, lemon-scented topical gel, in a 55-gallon drum (NDC 77512-044-03), from lot 2133607 (manufacturing date 11/23/21). The label does not contain an...
The recall affects Integrity Biochem HSC 70-LM, alcohol antiseptic 70%, hand sanitizer, lemon-scented topical gel, in a 55-gallon drum (NDC 77512-044-03), from lot 2133607 (manufacturing date 11/23/21). The label does not contain an...
The recall affects Integrity...
11/29/2023
Pharmacy Learning Network

Advertisement

News
Proton Pump Inhibitor Recalled
11/29/2023
Jolynn Tumolo
Glenmark Pharmaceuticals Inc. USA is recalling 30- and 100-count bottles of esomeprazole magnesium delayed-release capsules. According to the November 29, 2023, US Food and Drug Administration (FDA) Enforcement Report, 18-month testing of the...
Glenmark Pharmaceuticals Inc. USA is recalling 30- and 100-count bottles of esomeprazole magnesium delayed-release capsules. According to the November 29, 2023, US Food and Drug Administration (FDA) Enforcement Report, 18-month testing of the...
Glenmark Pharmaceuticals Inc....
11/29/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use